Reckitt Benckiser Group (LON:RKT – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at UBS Group in a research report issued on Friday, Marketbeat.com reports. They currently have a GBX 7,700 price target on the stock. UBS Group’s price target would suggest a potential upside of 30.29% from the company’s current price.
Several other research firms have also recently weighed in on RKT. Berenberg Bank lowered their price objective on Reckitt Benckiser Group from GBX 5,920 to GBX 5,555 and set a “hold” rating on the stock in a research report on Wednesday, August 6th. Jefferies Financial Group reiterated a “hold” rating and set a GBX 5,200 price objective on shares of Reckitt Benckiser Group in a research report on Thursday, October 2nd. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a GBX 5,300 price objective on shares of Reckitt Benckiser Group in a research report on Monday, July 21st. Finally, Royal Bank Of Canada increased their price objective on Reckitt Benckiser Group from GBX 5,700 to GBX 6,000 and gave the stock an “outperform” rating in a research report on Thursday, July 24th. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of GBX 5,951.
Get Our Latest Stock Analysis on RKT
Reckitt Benckiser Group Stock Up 1.8%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The company reported GBX 141.20 earnings per share for the quarter. Reckitt Benckiser Group had a return on equity of 18.70% and a net margin of 10.78%. As a group, research analysts expect that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current year.
Insider Buying and Selling
In other Reckitt Benckiser Group news, insider Jeremy Darroch acquired 1,652 shares of Reckitt Benckiser Group stock in a transaction that occurred on Tuesday, July 29th. The shares were acquired at an average cost of GBX 5,649 per share, with a total value of £93,321.48. Also, insider Margherita Della acquired 267 shares of Reckitt Benckiser Group stock in a transaction that occurred on Tuesday, July 29th. The stock was acquired at an average cost of GBX 5,649 per share, for a total transaction of £15,082.83. Insiders have purchased a total of 2,212 shares of company stock worth $12,488,849 over the last three months. Company insiders own 0.42% of the company’s stock.
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- Stock Average Calculator
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- The 3 Best Blue-Chip Stocks to Buy Now
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.